首页> 外文期刊>Mutation Research: International Journal on Mutagenesis, Chromosome Breakage and Related Subjects >Somatic mutation of the glucose-6-phosphate dehydrogenase (g6pd) gene in colonic stem cells and crypt restricted loss of G6PD activity.
【24h】

Somatic mutation of the glucose-6-phosphate dehydrogenase (g6pd) gene in colonic stem cells and crypt restricted loss of G6PD activity.

机译:结肠干细胞中葡萄糖-6-磷酸脱氢酶(g6pd)基因的体细胞突变和隐窝限制了G6PD活性的丧失。

获取原文
获取原文并翻译 | 示例
           

摘要

The study of somatic mutation frequency, particularly stem cell somatic mutation, is important to the understanding of mechanisms of carcinogenesis. The models currently in use for studies in stem cell tissues such as the colon infer the presence of stem cell somatic mutation from alteration in enzyme function, when this has shown to be mutagen dose dependent, restricted to the unit of clonal architecture, and persistent. The present study identifies and characterises somatic mutations in the g6pd gene in individual mouse colonic crypts showing histochemically demonstrable loss of G6PD activity. Microdissection of single crypts, showing either normal or low G6PD activity by histochemistry was performed in mice treated with ethylnitrosourea (ENU), and the presence of point mutations sought by PCR and direct sequencing. Because of the limitation of the small amount of partially degraded (due to fixation) DNA available from each crypt, only about 20% of the coding region of the g6pd gene could be sequenced. Despite this, somatic mutations were identified in 3 of the 9 crypts analysed which showed loss of G6PD activity, but in none of the crypts with normal activity. Each of the mutations identified would be predicted to lead to a decrease in enzyme activity. We conclude that we have confirmed that the crypt restricted loss of G6PD activity is indeed due to stem cell somatic mutation in the g6pd gene, and suggest that the G6PD model can be used as a paradigm for other models where somatic mutation is inferred from a change in histochemically identifiable gene expression.
机译:体细胞突变频率,特别是干细胞体细胞突变的研究,对于理解致癌机制很重要。当前已在诸如结肠之类的干细胞组织研究中使用的模型从酶功能的改变中推断出干细胞体细胞突变的存在,这已经证明是诱变剂剂量依赖性的,限于克隆结构的单位并且是持久的。本研究鉴定并表征了单个小鼠结肠隐窝中g6pd基因的体细胞突变,显示了组织化学上可证明的G6PD活性丧失。在用乙基亚硝基脲(ENU)处理的小鼠中进行了单个隐窝的显微解剖,通过组织化学显示了正常的或低的G6PD活性,并通过PCR和直接测序寻求了点突变的存在。由于每个隐窝都有少量的部分降解(由于固定)DNA的限制,因此只能对g6pd基因编码区的20%进行测序。尽管如此,在分析的9个隐窝中有3个发现了体细胞突变,显示G6PD活性丧失,但没有一个隐窝具有正常的活动。鉴定出的每个突变都将导致酶活性降低。我们得出的结论是,我们已经证实,G6PD的隐窝限制丧失确实是由于g6pd基因中的干细胞体细胞突变所引起的,并建议G6PD模型可以用作其他模型的范例,这些模型是通过变化推断出体细胞突变的在组织化学上可鉴定的基因表达中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号